Dexcom DXCM
NASDAQ DXCM
$92.34 +2.12 (+2.35%)
At close: Aug 21, 2026 · 4:00 PM EDT

Dexcom (DXCM) Short-Term Debt issuances (2017)

Dexcom (DXCM) posted quarterly Short-Term Debt issuances of $75.0 million for Q1 2017.

Dexcom (DXCM) Short-Term Debt issuances (2017) Analysis & Trends

Dexcom (DXCM) has reported Short-Term Debt issuances for 1 consecutive years, with $75.0 million the latest figure, recorded in Q1 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Short-Term Debt issuances (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn 64.00 Mn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn -
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn -164.00 Mn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn 1.42 Bn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn -
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn -
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn -47.66 Mn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn -37.80 Mn
10 Zimmer Biomet Holdings 19.42 Bn 19.01 Bn 1.54 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2017 75.00 Mn
Mar 31, 2017 75.00 Mn